The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery

<p>Abstract</p> <p>Background</p> <p>Intensive insulin therapy to maintain normoglycemia after cardiac surgery reduces morbidity and mortality. We investigated the magnitude and duration of hyperglycemia caused by dexamethasone administered after cardiopulmonary bypass....

Full description

Bibliographic Details
Main Authors: Boonstra Piet W, van der Horst Iwan CC, Janse Marcel, Drost José T, Hoekstra Miriam, Vogelzang Mathijs, Zijlstra Felix, Loef Bert G, Nijsten Maarten WN
Format: Article
Language:English
Published: BMC 2007-12-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/6/1/39
_version_ 1811275991607148544
author Boonstra Piet W
van der Horst Iwan CC
Janse Marcel
Drost José T
Hoekstra Miriam
Vogelzang Mathijs
Zijlstra Felix
Loef Bert G
Nijsten Maarten WN
author_facet Boonstra Piet W
van der Horst Iwan CC
Janse Marcel
Drost José T
Hoekstra Miriam
Vogelzang Mathijs
Zijlstra Felix
Loef Bert G
Nijsten Maarten WN
author_sort Boonstra Piet W
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Intensive insulin therapy to maintain normoglycemia after cardiac surgery reduces morbidity and mortality. We investigated the magnitude and duration of hyperglycemia caused by dexamethasone administered after cardiopulmonary bypass.</p> <p>Methods</p> <p>A single-center before-after cohort study was performed. All consecutive patients undergoing coronary artery bypass grafting with cardiopulmonary bypass during a 6-month period were included. Insulin administration was guided by a sliding scale protocol. Halfway the observation period, the dexamethasone protocol was changed. The single dose (1D) group received a pre-operative dose of dexamethasone of 1 mg/kg. The double dose group (2D) received an additional dose of 0.5 mg/kg of dexamethasone post-operatively at ICU admission.</p> <p>Results</p> <p>We included 116 patients in the 1D group and 158 patients in the 2D group. There were no significant baseline differences between the groups. Median Euroscore was 5. In univariable analysis, the glucose level was different between groups 1D and 2D at 4, 6, 9, 12 and 24 hours after ICU admission (all p < 0.001). Insulin infusion was higher in the 1D group. Corrected for insulin dose in multivariable linear analysis, the difference in glucose between the 1D and 2D groups was 1.5 mmol/L (95% confidence interval 1.0–2.0, p < 0.001) 12 hours after ICU admission.</p> <p>Conclusion</p> <p>Dexamethasone exerts a hyperglycemic effect in cardiac surgery patients. Patients receiving high-dose corticosteroid therapy should be monitored and treated more intensively for hyperglycemic episodes.</p>
first_indexed 2024-04-12T23:48:28Z
format Article
id doaj.art-c9dd70a2ab8b49208187eafdddcd8c4b
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-04-12T23:48:28Z
publishDate 2007-12-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-c9dd70a2ab8b49208187eafdddcd8c4b2022-12-22T03:11:48ZengBMCCardiovascular Diabetology1475-28402007-12-01613910.1186/1475-2840-6-39The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgeryBoonstra Piet Wvan der Horst Iwan CCJanse MarcelDrost José THoekstra MiriamVogelzang MathijsZijlstra FelixLoef Bert GNijsten Maarten WN<p>Abstract</p> <p>Background</p> <p>Intensive insulin therapy to maintain normoglycemia after cardiac surgery reduces morbidity and mortality. We investigated the magnitude and duration of hyperglycemia caused by dexamethasone administered after cardiopulmonary bypass.</p> <p>Methods</p> <p>A single-center before-after cohort study was performed. All consecutive patients undergoing coronary artery bypass grafting with cardiopulmonary bypass during a 6-month period were included. Insulin administration was guided by a sliding scale protocol. Halfway the observation period, the dexamethasone protocol was changed. The single dose (1D) group received a pre-operative dose of dexamethasone of 1 mg/kg. The double dose group (2D) received an additional dose of 0.5 mg/kg of dexamethasone post-operatively at ICU admission.</p> <p>Results</p> <p>We included 116 patients in the 1D group and 158 patients in the 2D group. There were no significant baseline differences between the groups. Median Euroscore was 5. In univariable analysis, the glucose level was different between groups 1D and 2D at 4, 6, 9, 12 and 24 hours after ICU admission (all p < 0.001). Insulin infusion was higher in the 1D group. Corrected for insulin dose in multivariable linear analysis, the difference in glucose between the 1D and 2D groups was 1.5 mmol/L (95% confidence interval 1.0–2.0, p < 0.001) 12 hours after ICU admission.</p> <p>Conclusion</p> <p>Dexamethasone exerts a hyperglycemic effect in cardiac surgery patients. Patients receiving high-dose corticosteroid therapy should be monitored and treated more intensively for hyperglycemic episodes.</p>http://www.cardiab.com/content/6/1/39
spellingShingle Boonstra Piet W
van der Horst Iwan CC
Janse Marcel
Drost José T
Hoekstra Miriam
Vogelzang Mathijs
Zijlstra Felix
Loef Bert G
Nijsten Maarten WN
The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
Cardiovascular Diabetology
title The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
title_full The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
title_fullStr The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
title_full_unstemmed The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
title_short The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
title_sort impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
url http://www.cardiab.com/content/6/1/39
work_keys_str_mv AT boonstrapietw theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT vanderhorstiwancc theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT jansemarcel theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT drostjoset theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT hoekstramiriam theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT vogelzangmathijs theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT zijlstrafelix theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT loefbertg theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT nijstenmaartenwn theimpactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT boonstrapietw impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT vanderhorstiwancc impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT jansemarcel impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT drostjoset impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT hoekstramiriam impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT vogelzangmathijs impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT zijlstrafelix impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT loefbertg impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery
AT nijstenmaartenwn impactofareduceddoseofdexamethasoneonglucosecontrolaftercoronaryarterybypasssurgery